New Advances in Nanomaterial‐Based Antiviral Strategies
Xican Xu, Jin Zhang, Shuang Liu, Chaohui Wang, Hongyu Wang, Huahao Fan, Yigang Tong, Huiyu Liu, Dongsheng Zhou
Abstract
The ongoing coronavirus disease 2019 (COVID‐19) pandemic and other major viral infectious diseases have become a significant threat to people's life and economic/social development. In recent years, with the development of nanotechnology, nanomaterial‐based antiviral agents have been extensively studied. However, the clinical applications of antiviral nanomaterials are still limited. Herein, the recent advances in nanomaterial‐based antiviral strategies, mainly including antiviral nanodrugs, drug nanocarriers, and nanovaccines, are summarized. The clinical challenges and prospects of nanomaterial‐based antiviral strategies are also discussed.